Avastin

Lung model
Research

Overcoming resistance to cancer I-O by targeting macrophages

A four-drug combination including immunotherapy, chemo and a CSF1R inhibitor could be strategy for treating NSCLC, a new study shows.
Angus Liu Aug 11, 2021 2:00pm
brown mouse

Roche's I-O antibody triplet shows promise in mouse tumor models

Jan 2, 2020 9:00am
3D brain against purple background

VBL sees Avastin-VB-111 phase 3 combo flop in brain cancer

Mar 8, 2018 8:35am
St Pancras Renaissance London

Cancer Research UK in $63M clinical trial boost

Feb 15, 2018 3:49am
Ignyta CEO

Roche splashes $1.7B in cash for Ignyta and entrectinib

Dec 22, 2017 4:21am
Research

Mateon cuts cancer combo test, costs as it refocuses efforts

Sep 27, 2017 9:03am